Literature DB >> 15929102

Waldenström macroglobulinemia: a review of therapy.

Morie A Gertz1.   

Abstract

Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

Entities:  

Mesh：

Year:  2005        PMID： 15929102     DOI： 10.1002/ajh.20363

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  3 in total

1.  Therapy with Chinese medicine in Waldenström's macroglobulinemia-associated retinal detachment.

Authors:  Fan Wang; Bai-Lin Song; Bin Yang
Journal:  Chin J Integr Med       Date:  2011-03-04       Impact factor: 1.978

2.  The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.

Authors:  Christopher J Klein; Joon-Shik Moon; Michelle L Mauermann; Steven R Zeldenrust; Yanhong Wu; Angela Dispenzieri; Peter J Dyck
Journal:  Can J Neurol Sci       Date:  2011-03       Impact factor: 2.104

3.  Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis.

Authors:  Xin Cao; Qing Ye; Robert Z Orlowski; Xiaoxiao Wang; Sanam Loghavi; Meifeng Tu; Sheeba K Thomas; Jatin Shan; Shaoying Li; Muzaffar Qazilbash; C Cameron Yin; Donna Weber; Roberto N Miranda; Zijun Y Xu-Monette; L Jeffrey Medeiros; Ken H Young
Journal:  J Hematol Oncol       Date:  2015-06-24       Impact factor: 17.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.